|
|
|
|
|
|
|
|
|
|
at the beginning of the year, Cellbox returns to Companisto for the last time – one of the most successful and most requested startups of 2025.
The reason for the reopening of the financing round is a decisive strategic milestone:
From March 2026, Dr. Bernd Mühlenweg will join the management of Cellbox. With over 25 years of international experience in the biotech and cell therapy industry – most recently as Senior Vice President at Evotec – he is specifically strengthening the company in a central growth phase.
Read more in the recently published Update.
|
|
|
|
|
|
|
The round is re-opened, but limited in time and with a limited participation option. After that, it will be finally closed.
Use the opportunity at the beginning of the year to participate once again in one of the most sought-after rounds of the past year. Participation is possible from 250 EUR. |
|
|
|
|
|
|
|
| INVESTMENT HIGHLIGHTS |
|
|
|
|
| • |
|
Disruptive, patented technology: First portable incubator for the transport of biological materials. |
|
|
| • |
|
Optimal transport conditions for living cells: perfect CO₂, hypoxia and temperature control for up to 48h. |
|
|
| • |
|
Fully certified & IATA-compliant for air transport: Freedom to Operate confirmed, strong IP protection. |
|
|
| • |
|
Already 250 boxes delivered to customers worldwide: including Roche, AstraZeneca, Grünenthal, Stanford and NIH. |
|
|
| • |
|
Strong investor base including Fraunhofer and NRW.BANK: Funding from EIC Accelerator (2.5 million EUR Grant + 6 million EUR potential mirroring by EIB). |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Companisto GmbH |
|
Köpenicker Str. 154, 10997 Berlin
Managing Director: Tamo Zwinge, LL. M. and David Rhotert
Amtsgericht: Berlin Charlottenburg HRB 132811 B
VAT-ID: DE 276 014 929
Phone: +49 30 330 837 49
Email: service@companisto.com |
|
|
|
|
|
|
|
|
| You receive this newsletter because you have subscribed to it. You can unsubscribe at any time via the unsubscribe link. |
|
| The acquisition of the offered securities and investments is associated with considerable risks and can lead to the complete loss of the invested assets. The expected yield is not guaranteed and may be lower. Whether it is a security or an asset investment can be seen in the description of the investment opportunity. |
|
|
|
|
